Drugs /
cd19 t-hank
Back to Drugs List
Overview
Clinical Trials
Cd19 t-hank has been investigated in 1 clinical trial, of which 0 are open and 1 is closed. Of the trial investigating cd19 t-hank, 1 is phase 1 (0 open).
Diffuse large B-cell lymphoma is the most common disease being investigated in cd19 t-hank clinical trials [2].
Drug Details
Drug Target(s) [2]:
CD19
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.
